348
Курс лекций по паллиативной медицине
102. Yusuf S, Gerstein H, Hoogwerf B, et al. Ramipril and the
development of diabetes. JAMA 2001; 286:1882.
103. Anker SD, Negassa A, Coats AJ, et al. Prognostic importance of
weight loss in chronic heart failure and the effect of treatment with
angiotensin-converting-enzyme inhibitors: an observational study.
Lancet 2003; 361:1077.
104. vanWetering CR, Hoogendoorn M, Broekhuizen R, et al. Efficacy
and costs of nutritional rehabilitation in muscle-wasted patients
with chronic obstructive pulmonary disease in a community-based
setting: a prespecified subgroup analysis of the INTERCOM trial. J
AmMedDirAssoc 2010; 11:179.
105. Boccanfuso JA, Hutton M, McAllister B. The effects of megestrol
acetate on nutritional parameters in a dialysis population. J
RenNutr 2000; 10:36.
106.
Burrowes JD, Bluestone PA, Wang J, Pierson RN Jr. The
effects of moderate doses of megestrol acetate on nutritional status
and body composition in a hemodialysis patient. J RenNutr 1999;
9:89.
107. Cheema B, Abas H, Smith B, et al. Progressive exercise for
anabolism in kidney disease (PEAK): a randomized, controlled
trial of resistance training during hemodialysis. J AmSocNephrol
2007; 18:1594.
108. Johansen KL, Painter PL, Sakkas GK, et al. Effects of resistance
exercise training and nandrolonedecanoate on body composition
and muscle function among patients who receive hemodialysis:
A randomized, controlled trial. J AmSocNephrol 2006; 17:2307.
